Research progress of HPV vaccine for preventing damage from HPV infection

Abstract

Human papillomavirus virus is one of the common infectious diseases in the world. HPV causes around 90% of the cervical cancers [1] and other diseases in males, females and bisexuals. In this article, the HPV vaccine is discussed as an effective way to prevent HPV intervention. The currently available HPV vaccines are 2, 4 and 9 valent which are all included in this article. The 2-valent targets 16, 18 types of HPV, the 4-valent and 9- valent can target 6, 11, 16, 18; 6, 11, 16, 18, 31, 33, 45, 52, and 58 types of HPV. The target populations of these 3 HPV vaccines are similar. Need to mention that many gender populations (males, females and bisexuals included) are all encouraged to take HPV vaccine at certain ages. The limitations of HPV vaccines cause the inhibition of the prevention of HPV and low inoculation rates worldwide, especially in developing countries. Limitations include inoculation age, target HPV types and vaccine price. This article also proposes a future tendency of research may on resolving these restrictions and promoting HPV vaccines in teenagers.